References
Arroyo V, Bosch J, Gaya-Beltran J, Kravetz D, Estrada L, Rivera F, Rodes J (1981) Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites. Ann Int Med 94:198
Arroyo V, Bosch J, Mauri M, Ribera F, Navarro-Lopez F, Rodes J (1981) Effect of angiotensin II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites. Eur J Clin Invest 11:221
Arroyo V, Bosch J, Rivera F, Rodes J (1979) The renin angiotensin system in cirrhosis: its relation to functional renal failure. In: Bartoli E, Chiandussi L (eds) Hepatorenal syndrome, Piccin, Padova, p 202
Bartoli E, Chiandussi L (eds) (1979) Hepatorenal syndrome. Piccin, Padova, Italy
Bernardi M, Trevisani F, Santini C, Zoli G, Baraldini M, Ligabue A, Gasbarrini G (1983) Plasma norepinephrine, weak neurotransmitters and renin activity during active tilting in liver cirrhosis: relationship with cardiovascular homeostasis and renal function. Hepatology 3:56
Bichet DG, Grines BG, Schrier RW (1984) Effect of head out water immersion on hepatorenal syndrome. Am J Kidney Dis 3:258
Cobden I, Shore A, Wilkinson R, Record CO (1985) Captopril in the hepatorenal syndrome. J Clin Gastroenterol 7:354
Daskalopoulos G, Jordan DR, Reynolds TB (1985) Randomized trial of peritoneovenous shunt in the treatment of the hepatorenal syndrome. Gastroenterology 88:1655 (Abstract)
Epstein M (ed) (1983) The kidney in liver disease, 2nd edn. Elsevier, New York
Epstein M, Berk DP, Hollenberg NK, Adams DF, Chalmers TC, Abrams HL, Merril JP (1970) Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med 49:175
Green J, Beyar R, Bomzon L, Finberg JPM, Better OS (1984) Jaundice, the circulation and the kidney. Nephron 37:145
Helwig FC, Schutz CB (1932) A liver kidney syndrome: clinical, pathological and experimental studies. Surg Gynecol Obstet 55:570
Henriksen JH, Ring-Larsen H, Christensen NH (1984) Sympathetic nervous activity in cirrhosis: a survey of plasma catecholamine studies. J Hepatology 1:55
Hunt S, Vaamonde CA, Rattassi T, Berian G, Said SI, Papper S (1979) Circulating levels of vasoactive intestinal polypeptide in liver disease. Arch Intern Med 139:994
Iwatsuki S, Modecai M, Popovtzer MM, Corman JL, Ishikawa M, Putnam CW, Katz F, Starlz T (1973) Recovery from “Hepato-renal syndrome”, after orthotopic liver transplantation. N Engl J Med 289:1155
Kanel GC, Peters RL (1984) Glomerular tubular reflux: a morphologic renal lesion associated with the hepatorenal syndrome. Hepatology 4:242
Kew MD, Varma RR, Williams HS, Brunt PW, Houriga KJ, Sherlock S (1971) Renal and intrarenal blood-flow in cirrhosis of the liver. Lancet 2:504
Kinney MJ, Schneider A, Wapnick S, Grosberg S, Le Veen H (1979) The hepatorenal syndrome and refractory ascites: successful therapy with the Le Veen type peritoneal-venous shunt and valve. Nephron 23:228
Kondo K, Nakamura R, Saito I, Saruta T, Matsuki S (1974) Renin, angiotensin II and juxtaglomerular apparatus in liver cirrhosis. Jpn Circ J 38:913
Koppel MH, Coburb JW, Mims MM, Goldstein H, Boyle JD, Rubini ME (1969) Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. N Engl J Med 280:1367
Lancestremere RG, Klinger EL Jr, Frisch E, Papper S (1963) Simultaneous determination of cardiac output and renal function in patients with Laennec's cirrhosis during the administration of the pressor amine, metaraminol. J Lab Clin Med 61:820
Laragh JH (1985) Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med 313:1330
Lieberman FL, Reynolds TB (1967) Plasma volume in cirrhosis of the liver: its relation to portal hypertension, ascites and renal failure. J Clin Invest 46:1297
Mandel AK, Lansing M, Fahmy A (1982) Acute tubular necrosis in hepatorenal syndrome: an electron microscopy study. Am J Kidney Dis 2:363
Papper S (1980) Hepatorenal syndrome. Contrib Nephrol 23:55
Ring-Larsen H, Henriksen JH, Christensen NJH (1983) Increased sympathetic activity in cirrhosis. N Engl J Med 308:1029
Ring-Larsen H, Hesse B, Stigsby SC (1976) Effect of portalsystemic anastomosis on renal hemodynamics in cirrhosis. Gut 17:856
Saruta T, Toyohisa E, Saito I (1983) Angiotensin antagonists in liver disease. In: Epstein M (ed) The kidney in liver disease, 2nd edn. Elsevier, New York, p 441
Schroeder ET, Anderson GH Jr, Smulyan H (1979) Effects of portacaval or peritoneovenus shunt on renin in the hepatorenal syndrome. Kidney Int 15:54
Schroeder ET, Shear L, Sancetta SM, Gabuzda GJ (1967) Renal failure in patients with cirrhosis of the liver. III Evaluation of intrarenal blood flow by para-aminohippurate extraction and response to angiotensin. Am J Med 43:887
Tristani FE, Cohn JN (1967) Systemic and renal hemodynamics in oliguric hepatic failure. Effect of volume expansion. J Clin Invest 46:1894
Vaamonde CA, Papper S (1979) The kidney in liver disease. In: Early LE, Gottschalk CW (eds) Strauss and Welt's diseases of the kidney, 3rd edn. Little, Brown and Company, Boston, p 1289
Wilkinson SP, Moodie H, Stamatakid JP, Kakker VV, Williams R (1976) Endotoxemia and renal failure in cirrhosis and obstructive jaundice. Br Med J 2:1415
Wilkinson SP, Weston MJ, Parson V, Williams R (1977) Dialysis in the treatment of renal failure in patients with liver disease. Clin Nephrol 8:287
Wilkinson SP, Williams R (1979) Defining “Hepatorenal syndrome”. In: Bartoli E, Chiandussi L (eds): Hepato renal syndrome, Piccin Medical Books, Padova, Italy, p 21
Wong PY, Talamo RC, William GH (1977) Kallikrein-kinin and renin-angiotensin system in functional renal failure of cirrhosis of the liver. Gastroenterology 73:1114
Zipser RD, Hoefs JC, Speckart PG, Zia PK, Horton R (1979) Prostaglandins: Modulators of renal function and pressor resistance in chronic liver disease. J Clin Endocrinol Metab 48:895
Zipser RD, Kerlin P, Hoefs J, Zia PK, Barg A (1981) Urinary kallikrein excretion in cirrhosis: relationship to other vasoactive systems. Am J Gastroenterol 75:183
Zipser RD, Kronborg I, Rector W, Reynolds T, Daskalopoulos G (1984) Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome. Gastroenterology 87:1228
Zipser RD, Radvan GH, Kronborg I, Duke R, Little TE (1983) Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: Evikdence for increased vasoconstrictor and decreased vasodilator factors. Gastroenterology 84:697
Zusman RM, Axelrod L, Tolkoff-Rubin N (1972) The treatment of the hepatorenal syndrome with intra-arterial administration of prostaglandin E2. Prostaglandins 13:819
Author information
Authors and Affiliations
Additional information
Dr. Pinzani is a visiting scholar from Istituto di Clinica Medica IV, Universita degli Studi di Firenze, Florence, Italy
Rights and permissions
About this article
Cite this article
Pinzani, M., Zipser, R.D. The hepatorenal syndrome. Intensive Care Med 13, 148–153 (1987). https://doi.org/10.1007/BF00254697
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00254697